Monoclonal antibody BR110 and uses thereof
US5840854A · kind A · utility
32Cited by
1References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 7, 1996 |
| Grant date | Nov 24, 1998 |
| Priority date | — |
| Expiry date | Oct 7, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/77
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides internalizing ligands (i.e., BR110 ligands) which specifically recognize and bind the BR110 antigen. After binding the antigen, the ligand and antigen form a complex. As a complex, the antigen can be detected using well known and developed methods and commercial systems.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.